Tesamorelin

Tesamorelin is a stabilised GHRH analogue — one of the most studied GHRH compounds — used specifically for its effect on visceral adipose tissue, alongside strength and lean-mass preservation in metabolic protocols. Typical Course: A full course runs 12 weeks at a consistent daily dose (2mg, administered at the same time each day) — consistency is critical for results. Most customers notice initial effects around week 4, with results continuing to build through week 12. What to Expect: Visceral fat reduction, GH-axis stimulation, lean mass preservation and improved cognitive clarity. Key benefits include a simple once-daily protocol, targeted visceral fat effects, no IGF-1 axis suppression and good overall tolerability. Considerations & Safety: Requires daily administration, and results tend to plateau by week 12; joint stiffness and water retention are possible. Common side effects include injection site reactions, joint pain, water retention and carpal-tunnel-like tingling. Seek medical attention immediately if you experience severe joint swelling, significant oedema, signs of glucose intolerance, or a spreading injection site reaction.